Special Report
-
Future Tense, Present Perfect: A strategy for debt funds
What route bond yields and interest rates take in the long term is anybody's guess. Short-term corporate bonds, therefore, are the best debt instruments in the current scenario
-
Small cap stocks: How should investors think through their portfolio?
Why it's best to stick to quality businesses and be prepared to wait it out
-
Why Alternative Investment Funds are catching the fancy of the uber-rich
The basket of Alternative Investment Funds has caught the fancy of the ultra-rich; pre-IPO companies, infrastructure funds and special situation funds are only making the pie sweeter
-
Here's why gold is a must-have in your portfolio
Gold may not beat equities in the long run but it is an avenue for wealth preservation in the short term
-
Investors, brace yourselves-2018 will be challenging
A host of factors point to a difficult year for equities
-
Startups and large businesses: A symbiotic relationship
The two forces coming together offers a world of opportunities in terms of exploring newer technologies along with the heft of experience and financial power
-
Forbes India Leadership Agenda: Corporate honchos discuss all things leadership
The leadership conclave, in association with Mercedes-Benz, will see TED-type talks and panel discussions by some of the outstanding leaders from India Inc.
-
Next gen in liquor businesses: In good spirits
The new generation leaders at three family-owned liquor businesses are trying to reassert their storied brands and create new niches
-
Forbes India Conversations: From globalisation to glocalisation
Interconnectedness in the world is at an all-time high and experts believe technology is bringing businesses ever closer
-
Furtados: Old notes, new melodies
Furtados, synonymous with Western music in India, has evolved and expanded to find new clients and revenue streams
-
The Singhs of ACG Worldwide: Capsule czars
With their fraternal camaraderie and complementary skills, Ajit and Jasjit Singh built ACG Worldwide into a global, diversified pharma services giant; now as next gen takes charge, there's still room to grow